Clinical trial NCT01049334 - References

Pharyngitis — A Study of Flurbiprofen 8.75 mg Lozenge in Patient With Pharyngitis

Citation(s)

•   Aspley S, Schachtel B, Berry P, Shephard A, Sanner K, Savino L, Rezuke J, Shea T, Smith G
  Treatment of odynophagia and dysphagia by flurbiprofen 8.75 mg lozenges. Pain Research & Management 2012;17(3):203.
•   Aspley S, Schachtel B, Berry P, Shephard A, Sanner K, Shea T, Smith G
  The Chief Complaint: evidence of its use as an endpoint in a clinical trial. Journal of Pain 2012;13(4)Supplement:S4.
•   Aspley S, Schachtel B, Berry P, Shephard A, Shea T, Smith G, Schachtel E
  Flurbiprofen lozenges in patients with a "bad sore throat". Journal of Pain 2013;14(4):S59.
•   Schachtel B, Aspley S, Berry P, Shephard A, Sanner K, Shea T, Smith G, Schachtel E
  Chief Complaint: the therapeutogenic stimulus as the primary, individualized endpoint in clinical trials. Journal of Pain 2012;13(4)Supplement:S6.
•   Schachtel B, Aspley S, Berry P, Shephard A, Shea T, Smith G, Sanner K, Savino L, Rezuke J, Schachtel E
  Efficacy and duration of flurbiprofen 8.75 mg lozenge. Clinical Pharmacology in Drug Development 2012;1(4):194.
•   Schachtel B, Aspley S, Berry P, Shephard A, Shea T, Smith G, Schachtel E
  A new cough model: de-hawthornizing a clinical trial. Clinical Pharmacology in Drug Development 2012;1(4):195.
•   Schachtel B, Aspley S, Berry P, Shephard A, Shea T, Smith G, Schachtel E
  The "Definite Improvement Level" (DIL) as a determinant of drug efficacy. Journal of Pain 2013;14(4):S5.
•   Schachtel B, Aspley S, Berry P, Shephard A, Shea T,Sanner K, Smith G,Schachtel E
  Efficacy of flurbiprofen 8.75mg lozenges in patients with swollen/inflamed sore throat. Abstract presented at the 14th World Congress on Pain, 27 - 31 August 2012, Milan.
•   Schachtel B, Aspley S, Berry P, Smith G, Shephard A, Shea T, Schachtel E
  A patient-centered method for determining onset of action. Clinical Pharmacology in Drug Development 2012;1(4):194-195.
•   Schachtel BP, Aspley S, Sternberg M, Berry P, Muir N, Sanner K, Rezuke J, Savino L, Shephard A, Shea T, Schachtel E
  Onset of demulcent and analgesic activity of flurbiprofen lozenge. Int J Clin Pharm 2012;34:143-258.
•   Schachtel BP, McCormick CG and Giefer EE
  Patient-reported outcomes (PRO's) in the pharyngitis pain model. Abstract presented at the International Association for the Study of Pain (IASP) Scientific Conference, Montreal, Canada. 2009
•   Shephard A, Smith G, Aspley S, Schachtel B
  Efficacy of flurbiprofen 8.75 mg lozenges for streptococcal and non-streptococcal sore throat: pooled analysis of two randomised, placebo-controlled studies. Abstract presented at the European Congress of Clinic
•   Shephard A, Smith G, Aspley S, Schachtel B
  Symptomatic relief in streptococcal and non-streptococcal sore throat patients: pooled analysis of two randomised, placebo-controlled studies. Abstract presented at the European Congress of Clinical Microbiology

A Randomized, Double-Blind, Placebo-Controlled Multiple-Dose Study to Determine the Efficacy, Onset, and Duration of Action of Flurbiprofen 8.75 mg Lozenge Compared to Its Vehicle Control Lozenge in Patients With Painful Pharyngitis

Details for clinical trial NCT01049334